Truist Financial Corp Invests $345,000 in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Truist Financial Corp acquired a new stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 4,422 shares of the company's stock, valued at approximately $345,000.

Several other institutional investors and hedge funds also recently made changes to their positions in PBH. Huntington National Bank increased its holdings in Prestige Consumer Healthcare by 39.9% in the 3rd quarter. Huntington National Bank now owns 635 shares of the company's stock worth $46,000 after buying an additional 181 shares in the last quarter. International Assets Investment Management LLC grew its holdings in shares of Prestige Consumer Healthcare by 7,112.5% in the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company's stock worth $83,000 after acquiring an additional 1,138 shares during the period. Covestor Ltd grew its holdings in shares of Prestige Consumer Healthcare by 95.6% in the third quarter. Covestor Ltd now owns 1,338 shares of the company's stock worth $96,000 after acquiring an additional 654 shares during the period. GAMMA Investing LLC grew its stake in shares of Prestige Consumer Healthcare by 18.9% during the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company's stock valued at $108,000 after purchasing an additional 220 shares during the period. Finally, Blue Trust Inc. grew its stake in shares of Prestige Consumer Healthcare by 24.8% during the 4th quarter. Blue Trust Inc. now owns 2,190 shares of the company's stock valued at $158,000 after purchasing an additional 435 shares during the period. Institutional investors own 99.95% of the company's stock.

Remove Ads

Prestige Consumer Healthcare Price Performance

Prestige Consumer Healthcare stock traded up $2.01 during mid-day trading on Friday, hitting $89.10. The stock had a trading volume of 604,737 shares, compared to its average volume of 328,521. The firm has a market capitalization of $4.41 billion, a P/E ratio of 20.87, a P/E/G ratio of 2.69 and a beta of 0.46. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. The firm's 50 day moving average is $80.80 and its 200 day moving average is $77.77. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $89.65.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, topping analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have issued reports on PBH. Raymond James upgraded Prestige Consumer Healthcare to a "moderate buy" rating in a research note on Thursday, December 19th. DA Davidson boosted their price objective on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research report on Friday, February 7th. StockNews.com raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Friday, January 24th. Canaccord Genuity Group boosted their price target on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a report on Friday, February 7th. Finally, Oppenheimer boosted their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a report on Thursday, February 13th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $92.60.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.